✦ LIBER ✦
Phase III double-blind, placebo-controlled, prospective randomized trial of adjuvant tamoxifen vs. tamoxifen and fenretinide in postmenopausal women with positive receptors (EB193): an intergroup trial coordinated by the Eastern Cooperative Oncology Group
✍ Scribed by Ruta D. Rao; Melody A. Cobleigh; Robert Gray; Mark L. Graham; Larry Norton; Silvana Martino; George Thomas Budd; James N. Ingle; William C. Wood
- Book ID
- 107577296
- Publisher
- Springer US
- Year
- 2010
- Tongue
- English
- Weight
- 281 KB
- Volume
- 28
- Category
- Article
- ISSN
- 1357-0560
No coin nor oath required. For personal study only.